Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Molecumetics and P&U enter collaboration for caspase research

Sep. 30, 1999

No Comments

Medarex enters HuMAb-Mouse antibody agreement with Amgen

Sep. 28, 1999

No Comments

Fournier synthesizes novel potent B2 agonists resistant to enzymatic degradation

Sep. 24, 1999

No Comments

Bristol-Myers Squibb enters target validation collaboration with Exelixis

Sep. 23, 1999

No Comments

M.D. Anderson Cancer Center and Cryogenic Solutions enter antisense collaboration

Sep. 22, 1999

No Comments

Japanese coalition formed for development of new drugs

Sep. 21, 1999

No Comments

Unique new selective FP receptor antagonist characterized by Alcon

Sep. 20, 1999

No Comments

Oxford GlycoSciences and Cellular Genomics form proteomics collaboration

Sep. 20, 1999

No Comments

Myriad Genetics establishes strategic alliance with Galileo Genomics

Sep. 17, 1999

No Comments

Neurocrine Biosciences and Arena establish research collaboration

Sep. 17, 1999

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies
RSS

Molecumetics and P&U enter collaboration for caspase research

Medarex enters HuMAb-Mouse antibody agreement with Amgen

Fournier synthesizes novel potent B2 agonists resistant to enzymatic degradation

Bristol-Myers Squibb enters target validation collaboration with Exelixis

M.D. Anderson Cancer Center and Cryogenic Solutions enter antisense collaboration

Japanese coalition formed for development of new drugs

Unique new selective FP receptor antagonist characterized by Alcon

Oxford GlycoSciences and Cellular Genomics form proteomics collaboration

Myriad Genetics establishes strategic alliance with Galileo Genomics

Neurocrine Biosciences and Arena establish research collaboration

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Drug design, drug delivery and technologies RSS

Drug design, drug delivery and technologies
RSS